Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 25 March 2025 - 16:45

Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 10, Status: Authorised

Submitted by Anonymous (not verified) on 25 March 2025 - 16:05

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 10, Status: Authorised

Second EMA / Alliance for Regenerative Medicine bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 May 2025, 14:00 (CEST) to 8 May 2025, 16:00 (CEST)

Submitted by Anonymous (not verified) on 25 March 2025 - 15:25

Second EMA / Alliance for Regenerative Medicine bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 May 2025, 14:00 (CEST) to 8 May 2025, 16:00 (CEST)

European Medicines Agency procedural advice on recommendations on unforeseen variations according to Article 5 of Commission Regulation (EC) No 1234/2008

Submitted by Anonymous (not verified) on 25 March 2025 - 13:35

European Medicines Agency procedural advice on recommendations on unforeseen variations according to Article 5 of Commission Regulation (EC) No 1234/2008

Human medicines European public assessment report (EPAR): Onpattro, patisiran, Date of authorisation: 27/08/2018, Revision: 14, Status: Authorised

Submitted by Anonymous (not verified) on 25 March 2025 - 12:53

Human medicines European public assessment report (EPAR): Onpattro, patisiran, Date of authorisation: 27/08/2018, Revision: 14, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness